Mohamed Hassan Nasraa

4PUBLICATIONS
4CO-AUTHORS
Sensory systemsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 07, 2026
Comparative Analysis of Nucleocapsid- and Spike-Specific Isotype Humoral Immune Responses Following Natural SARS-CoV-2 Infection and Vaccination with Sinopharm, Sinovac, and AstraZeneca.

|Mar 24, 2026
Correction to: Chemotherapy of breast cancer cells alters susceptibility to complement‑mediated opsonization and killing.

Mohamed Hassan Nasraa, Mahmoud Mohamed Bahgat, Michael Kirschfinik

|Jun 19, 2025
Chemotherapy of breast cancer cells alters susceptibility to complement-mediated opsonization and killing.

Mohamed Hassan Nasraa, Mahmoud Mohamed Bahgat, Michael Kirschfinik

|Jan 24, 2024
Analysis of the SARS-CoV-2 nsp12 P323L/A529V mutations: coeffect in the transiently peaking lineage C.36.3 on protein structure and response to treatment in Egyptian records.

Dina N Abd-Elshafy, Rola Nadeem, Mohamed H Nasraa

Pageof 1

Frequent Collaborators

3 joint publications

Mahmoud Mohamed Bahgat

2 joint publications

Michael Kirschfinik

1 joint publications

Dina N Abd-Elshafy

1 joint publications

Rola Nadeem